Viewing Study NCT05240404


Ignite Creation Date: 2025-12-24 @ 9:11 PM
Ignite Modification Date: 2026-02-01 @ 4:15 AM
Study NCT ID: NCT05240404
Status: UNKNOWN
Last Update Posted: 2022-02-15
First Post: 2022-02-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Adjuvant Immunotherapy With Toripalimab Following Curative-intent Ablation for Recurrent Hepatocarcinoma
Sponsor: Xiangya Hospital of Central South University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Immunotherapy View
None Toripalimab View